Insights
Perspectives on readmission risk, GLP-1 adherence, and the operational realities of value-based care.

GLP-1
GLP-1 programs measure who starts therapy. The harder question is who stays on it, and whether anyone sees the warning signs before a patient disappears from treatment.

Readmissions
Research puts preventable readmissions at roughly one in four. What that ceiling means for hospital programs, vendor claims, and how to measure what worked.

Clinical Adoption
Clinicians ignore risk scores because the scores have earned it. The answer is not more training. It is patient level reasoning that directs action.
15 minutes is all it takes to see what Preventra can do for your organization.
Request a 15-Min Walkthrough